Chart Industries GTLS Biomedical — Intangible Impairment
Discontinued — last reported Q4 '15
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Chart Industries in its filing.
Tagged under the XBRL concept us-gaap:ImpairmentOfIntangibleAssetsFinitelived.
The official record: Chart Industries’s 10-K, filed February 22, 2018, on SEC EDGAR. View the filing →
Questions, answered.
- What does biomedical — intangible impairment mean?
- The write-down of the value of finite-lived intangible assets due to reduced expected future utility.
- How do you interpret biomedical — intangible impairment?
- Higher charges suggest that specific segment assets are losing value faster than originally projected.
- How does biomedical — intangible impairment compare across companies?
- Similar to 'Amortization and Impairment of Intangibles' reported by peers in the medical technology sector.